RENAISSANCE TECHNOLOGIES LLC
Institutional investor · Portfolio as of Q2 2025
Top Holdings3,522 positions
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction |
|---|---|---|---|---|---|---|---|
PALANTIR TECHNOLOGIES INC-A | 13.5M | $1.8B | 2.4% | $13.82 | +846.12% | 17 qtrssince 2021-Q2 | Decreased 0 |
NVIDIA CORP | 7.4M | $1.2B | 1.6% | $151.82 | +3.89% | 10 qtrssince 2023-Q1 | Increased 81 |
ROBINHOOD MARKETS INC - A | 11.5M | $1.1B | 1.4% | $26.77 | +210.14% | 12 qtrssince 2022-Q3 | Decreased 0 |
VERISIGN INC | 3.3M | $943.6M | 1.3% | $200.20 | +42.84% | 23 qtrssince 2019-Q4 | Increased 55 |
NETFLIX INC | 538,528 | $721.2M | 1.0% | $132.26 | +0.04% | 5 qtrssince 2024-Q2 | Increased 72 |
EXELIXIS INC | 15.8M | $697.3M | 0.9% | $20.43 | +113.78% | 23 qtrssince 2019-Q4 | Increased 48 |
SPOTIFY TECHNOLOGY SA | 881,925 | $676.7M | 0.9% | $308.72 | +150.26% | 14 qtrssince 2022-Q1 | Increased 48 |
SPROUTS FMRS MKT INC | 4M | $663.8M | 0.9% | $30.44 | +432.65% | 23 qtrssince 2019-Q4 | Decreased 0 |
ROBLOX CORP -CLASS A | 6.1M | $641.9M | 0.9% | $55.76 | +89.36% | 17 qtrssince 2021-Q2 | Increased 44 |
GILEAD SCIENCES INC | 5.7M | $628.2M | 0.8% | $67.71 | +61.26% | 23 qtrssince 2019-Q4 | Increased 46 |
GE VERNOVA LLC | 1.2M | $622.5M | 0.8% | $432.04 | +20.09% | 4 qtrssince 2024-Q3 | Increased 72 |
UNITED THERAPEUTICS CORP | 2.1M | $608.9M | 0.8% | $98.80 | +187.72% | 23 qtrssince 2019-Q4 | Increased 45 |
DOORDASH INC - A | 2.5M | $607.4M | 0.8% | $128.92 | +87.96% | 17 qtrssince 2021-Q2 | Increased 54 |
FRANCO-NEVADA CORP /CAD/ | 3.3M | $534M | 0.7% | $110.16 | +46.44% | 23 qtrssince 2019-Q4 | Increased 48 |
KINROSS GOLD CORP | 33.5M | $523.2M | 0.7% | $5.20 | +185.66% | 23 qtrssince 2019-Q4 | Increased 46 |
APPLOVIN CORP-CLASS A | 1.4M | $483.4M | 0.6% | $279.12 | +19.58% | 7 qtrssince 2023-Q4 | Increased 63 |
FORD MOTOR CO | 43.5M | $471.8M | 0.6% | $10.05 | +3.73% | 11 qtrssince 2022-Q4 | Increased 71 |
APPLE INC | 2.3M | $469.1M | 0.6% | $204.21 | -0.01% | 20 qtrssince 2020-Q3 | Increased 71 |
CORCEPT THERAPEUTICS INC | 6.3M | $460M | 0.6% | $15.07 | +385.76% | 23 qtrssince 2019-Q4 | Increased 45 |
VERTEX PHARMACEUTICALS INC | 1M | $447.4M | 0.6% | $271.46 | +62.57% | 23 qtrssince 2019-Q4 | Decreased 0 |
RENAISSANCE TECHNOLOGIES LLC manages $75.2B across 3522 positions as of Q2 2025. Top holdings: PLTR (2.4%), NVDA (1.6%), HOOD (1.4%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 3.5/5.0.
Active quarter - 618 new positions, 502 exits, 1564 increased. Top move: NVDA (INCREASED, conviction 81). Portfolio: $75.2B across 3522 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer